Publications by authors named "S Uhrig"

Claim this Profile
I
Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial.
Milena Beierlein, Lothar Häberle, Naiba Nabieva, Nicolai Maass, Bahriye Aktas, Sabrina Uhrig

Int J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall Survival in Metastatic Breast Cancer Patients: Real-World Data from 1,000 Patients Treated at the NCT Heidelberg between 2014 and 2022.
Laura L Michel, Manuel Feisst, Verena Thewes, Dirk Jäger, Andreas D Hartkopf, Sabrina Uhrig

Breast Care (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer.
Laura L Michel, Philipp Ziegler, Philipp Kreis, Andreas D Hartkopf, Markus Wallwiener, Sabrina Uhrig

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to digital pregnancy care - lessons learned from the SMART start feasibility study.
Katharina M Jaeger, Michael Nissen, Heike Leutheuser, Nina Danzberger, Adriana Titzmann, Sabrina Uhrig

NPJ Digit Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer - the SERAPHINA study.
Andreas Schneeweiss, Peter A Fasching, Marc Thill, Marion van Mackelenbergh, Frederik Marme, Sabrina Uhrig

J Cancer Res Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis